Browsing by Author "Adegboye, Oyelola A."

Now showing items 1-8 of 8

    • Analysis of spatial data with a nested correlation structure 

      Adegboye, Oyelola A.; Leung, Denis H. Y; Wang, You-Gan ( Wiley , 2017 , Article)
      Spatial statistical analyses are often used to study the link between environmental factors and the incidence of diseases. In modelling spatial data, the existence of spatial corre- lation between observations must be ...

    • Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 

      Dana, Bryazka; Reitsma, Marissa B; Abate, Yohannes Habtegiorgis; Abd Al Magied, Abdallah H A; Abdelkader, Atef; ... more authors ( Elsevier , 2024 , Article)
      BackgroundSmoking is the leading behavioural risk factor for mortality globally, accounting for more than 175 million deaths and nearly 4·30 billion years of life lost (YLLs) from 1990 to 2021. The pace of decline in smoking ...

    • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 

      Schumacher, Austin E.; Kyu, Hmwe Hmwe; Aali, Amirali; Abbafati, Cristiana; Abbas, Jaffar; ... more authors ( Elsevier , 2024 , Article)
      Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely ...

    • The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 

      Khanh Bao, Tran; Lang, Justin J; Compton, Kelly; Xu, Rixing; Acheson, Alistair R; ... more authors ( Elsevier , 2022 , Article)
      BackgroundUnderstanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global ...

    • Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 

      Yingzhao, Jin; Guo, Cui; Abbasian, Mohammadreza; Abbasifard, Mitra; Abbott, J. Haxby; ... more authors ( Elsevier , 2024 , Article)
      BackgroundThis study aims to estimate the burden, trends, forecasts, and disparities of early musculoskeletal (MSK) disorders among individuals ages 15 to 39 years. MethodsThe global prevalence, years lived with disabilities ...

    • Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 

      Austin, Carter; Zhang, Meixin; Tram, Khai Hoan; Walters, Magdalene K; Jahagirdar, Deepa; ... more authors ( Elsevier , 2024 , Article)
      BackgroundAs set out in Sustainable Development Goal 3.3, the target date for ending the HIV epidemic as a public health threat is 2030. Therefore, there is a crucial need to evaluate current epidemiological trends and ...

    • Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021. 

      Rautalin, Ilari; Volovici, Victor; Stark, Benjamin A; Johnson, Catherine O; Kaprio, Jaakko; ... more authors ( American Medical Association , 2025 , Article)
      Nontraumatic subarachnoid hemorrhage (SAH) represents the third most common stroke type with unique etiologies, risk factors, diagnostics, and treatments. Nevertheless, epidemiological studies often cluster SAH with other ...

    • Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: a retrospective examination of real-world cohort 

      Sukik, Aseel; Aboughalia, Ahmed Tarek; Said Wali, Abdul Haseeb; Al Radaideh, Amro; Elsayed, Omar Mohamed; ... more authors ( Frontiers Media S.A. , 2025 , Article)
      Background: Polypharmacy is a rising morbidity amongst patients with chronic heart failure (CHF), with reported prevalence ranging from 70% to 85%. While polypharmacy is essential for managing comorbid conditions, its exact ...